Peter Bettelheim

8.1k total citations · 1 hit paper
153 papers, 5.7k citations indexed

About

Peter Bettelheim is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, Peter Bettelheim has authored 153 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Hematology, 61 papers in Genetics and 51 papers in Immunology. Recurrent topics in Peter Bettelheim's work include Acute Myeloid Leukemia Research (47 papers), Mast cells and histamine (28 papers) and Chronic Lymphocytic Leukemia Research (22 papers). Peter Bettelheim is often cited by papers focused on Acute Myeloid Leukemia Research (47 papers), Mast cells and histamine (28 papers) and Chronic Lymphocytic Leukemia Research (22 papers). Peter Bettelheim collaborates with scholars based in Austria, Germany and France. Peter Bettelheim's co-authors include Peter Valent, Klaus Lechner, Otto Majdic, Christian Sillaber, Klaus Geißler, Walter Knapp, W Hinterberger, J Besemer, E. Liehl and K Liszka and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Peter Bettelheim

148 papers receiving 5.4k citations

Hit Papers

Identification of Profili... 1991 2026 2002 2014 1991 100 200 300 400 500

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Peter Bettelheim 2.2k 2.1k 1.2k 1.2k 1.1k 153 5.7k
Philippe Lesavre 3.0k 1.4× 1.1k 0.5× 678 0.6× 1.3k 1.1× 863 0.8× 107 6.5k
Henrik Sengeløv 2.2k 1.0× 1.4k 0.7× 647 0.5× 1.9k 1.6× 320 0.3× 149 6.2k
J S Pober 2.6k 1.2× 912 0.4× 1.5k 1.2× 1.3k 1.1× 213 0.2× 39 5.6k
J Breton-Gorius 1.1k 0.5× 3.6k 1.7× 427 0.3× 1.2k 1.0× 1.3k 1.2× 112 5.6k
Christopher D. Benjamin 3.2k 1.5× 782 0.4× 1.5k 1.2× 1.3k 1.1× 233 0.2× 58 5.9k
F. Herrmann 2.3k 1.1× 2.0k 1.0× 213 0.2× 1.4k 1.1× 671 0.6× 149 5.6k
Philip E. Hass 2.1k 0.9× 1.7k 0.8× 455 0.4× 1.8k 1.5× 577 0.5× 36 5.6k
Richard J. Riese 2.2k 1.0× 1.0k 0.5× 395 0.3× 1.6k 1.3× 568 0.5× 76 7.2k
Kazuya Shimoda 2.9k 1.3× 1.6k 0.8× 248 0.2× 1.9k 1.6× 1.3k 1.2× 250 6.4k
G. S. Hodgson 2.6k 1.2× 1.6k 0.8× 221 0.2× 1.6k 1.3× 750 0.7× 107 5.8k

Countries citing papers authored by Peter Bettelheim

Since Specialization
Citations

This map shows the geographic impact of Peter Bettelheim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Bettelheim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Bettelheim more than expected).

Fields of papers citing papers by Peter Bettelheim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Bettelheim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Bettelheim. The network helps show where Peter Bettelheim may publish in the future.

Co-authorship network of co-authors of Peter Bettelheim

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Bettelheim. A scholar is included among the top collaborators of Peter Bettelheim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Bettelheim. Peter Bettelheim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bauer, Karin, Alexander W. Hauswirth, Karoline V. Gleixner, et al.. (2024). BRD4 degraders may effectively counteract therapeutic resistance of leukemic stem cells in AML and ALL. American Journal of Hematology. 99(9). 1721–1731. 15 indexed citations
2.
Heibl, Sonja, Bettina Gisslinger, Peter Bettelheim, et al.. (2020). Clinical, Hematologic, Biologic and Molecular Characteristics of Patients with Myeloproliferative Neoplasms and a Chronic Myelomonocytic Leukemia-Like Phenotype. Cancers. 12(7). 1891–1891. 4 indexed citations
3.
Valent, Peter, Karl Sotlar, K. Blatt, et al.. (2017). Proposed diagnostic criteria and classification of basophilic leukemias and related disorders. Leukemia. 31(4). 788–797. 35 indexed citations
4.
Schrezenmeier, Hubert, Peter Bettelheim, Jens Panse, et al.. (2012). Recommendations for the diagnosis of paroxysmal nocturnal hemoglobinuria: a German-Austrian Consensus1). LaboratoriumsMedizin. 35(6). 2 indexed citations
5.
Béné, Marie C., Thomas Nebe, Peter Bettelheim, et al.. (2011). Immunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European LeukemiaNet Work Package 10. Leukemia. 25(4). 567–574. 127 indexed citations
6.
Valent, Peter, O. Krieger, Reinhard Stauder, et al.. (2008). Iron overload in myelodysplastic syndromes (MDS) – diagnosis, management, and response criteria: a proposal of the Austrian MDS platform. European Journal of Clinical Investigation. 38(3). 143–149. 44 indexed citations
7.
Schrenk, Peter, Peter Bettelheim, R. Woisetschläger, R. Rieger, & W. Wayand. (1996). Metabolic responses after laparoscopic or open hernia repair. Surgical Endoscopy. 10(6). 628–632. 23 indexed citations
8.
Agis, Hermine, Waltraud J. Beil, Hans Bankl, et al.. (1996). Mast Cell-Lineage Versus Basophil Lineage Involvement in Myeloproliferative and Myelodysplastic Syndromes: Diagnostic Role of Cell-Immunopheno typing. Leukemia & lymphoma. 22(3-4). 187–204. 34 indexed citations
9.
Sillaber, Christian, Dorian Bevec, Joseph H. Butterfield, et al.. (1993). Tumor necrosis factor alpha and interleukin-1 beta mRNA expression in HMC-1 cells: differential regulation of gene product expression by recombinant interleukin-4.. PubMed. 21(9). 1271–5. 58 indexed citations
10.
Köller, Ursula, O. A. Haas, W. D. Ludwig, et al.. (1991). Acute megakaryoblastic leukemia a comparison of phenotypic genotypic and clinical features in children and adults. 32. 179. 1 indexed citations
11.
Sunder‐Plassmann, Gere, Wolfgang Speiser, C Korninger, et al.. (1991). Disseminated intravascular coagulation and decrease in fibrinogen levels induced by vincristine/prednisolone therapy of lymphoid blast crisis of chronic myeloid leukemia. Annals of Hematology. 62(5). 169–173. 6 indexed citations
12.
Valent, Peter, Christian Sillaber, & Peter Bettelheim. (1991). The growth and differentiation of mast cells. PubMed. 3(1). 27–41. 45 indexed citations
13.
Schwarzinger, Ilse, Peter Valent, Ursula Köller, et al.. (1990). Prognostic significance of surface marker expression on blasts of patients with de novo acute myeloblastic leukemia.. Journal of Clinical Oncology. 8(3). 423–430. 79 indexed citations
14.
Geißler, Klaus, W Hinterberger, Peter Bettelheim, et al.. (1988). Deficiency of pluripotent hemopoietic progenitor cells in myelodysplastic syndromes. Annals of Hematology. 57(1). 45–49. 16 indexed citations
15.
Lechner, Katharina, C Korninger, H. Niessner, et al.. (1987). [Oral anticoagulant therapy--renaissance of an old therapy?].. PubMed. 99(7). 203–10. 1 indexed citations
16.
Pirker, Robert, et al.. (1986). B-Immunoblastic Lymphoma Arising in Angioimmunoblastic Lymphadenopathy. Acta Haematologica. 75(2). 105–109. 10 indexed citations
17.
Krieger, O., et al.. (1986). Klinische Wertigkeit verschiedener Klassifikationen bei Erwachsenen mit AML. Oncology Research and Treatment. 9(2). 67–71. 1 indexed citations
18.
Gadner, Helmut, et al.. (1985). [Cooperative studies in the treatment of acute lymphoblastic leukemia in children in Austria--report of 10 years' experience].. PubMed. 97(3). 140–8. 2 indexed citations
19.
Mueller‐Eckhardt, C., Klaus Lechner, D. Heinrich, et al.. (1980). Post-transfusion thrombocytopenic purpura: Immunological and clinical studies in two cases and review of the literature. Annals of Hematology. 40(4). 249–257. 27 indexed citations
20.
Rainer, H., Keith Moser, & Peter Bettelheim. (1978). [Randomized study: chemotherapy versus chemotherapy plus transfer factor in metastasized breast neoplasm].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 604–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026